Robert L. Matts - Publications

Biochemistry & Molecular Biology Oklahoma State University, Stillwater, OK, United States 

88 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Voruganti S, Kline JT, Balch MJ, Rogers J, Matts RL, Hartson SD. Proteomic Profiling of Hsp90 Inhibitors. Methods in Molecular Biology (Clifton, N.J.). 1709: 139-162. PMID 29177657 DOI: 10.1007/978-1-4939-7477-1_11  0.64
2015 Sun L, Hartson SD, Matts RL. Identification of proteins associated with Aha1 in HeLa cells by quantitative proteomics. Biochimica Et Biophysica Acta. 1854: 365-80. PMID 25614414 DOI: 10.1016/J.Bbapap.2015.01.002  1
2014 Davenport J, Balch M, Galam L, Girgis A, Hall J, Blagg BS, Matts RL. High-throughput screen of natural product libraries for hsp90 inhibitors. Biology. 3: 101-38. PMID 24833337 DOI: 10.3390/Biology3010101  1
2014 Manjarrez JR, Sun L, Prince T, Matts RL. Hsp90-dependent assembly of the DBC2/RhoBTB2-Cullin3 E3-ligase complex. Plos One. 9: e90054. PMID 24608665 DOI: 10.1371/Journal.Pone.0090054  1
2013 Sadikot T, Swink M, Eskew JD, Brown D, Zhao H, Kusuma BR, Rajewski RA, Blagg BS, Matts RL, Holzbeierlein JM, Vielhauer GA. Development of a high-throughput screening cancer cell-based luciferase refolding assay for identifying Hsp90 inhibitors. Assay and Drug Development Technologies. 11: 478-88. PMID 24127661 DOI: 10.1089/Adt.2012.498  1
2013 Voruganti S, Lacroix JC, Rogers CN, Rogers J, Matts RL, Hartson SD. The anticancer drug AUY922 generates a proteomics fingerprint that is highly conserved among structurally diverse Hsp90 inhibitors. Journal of Proteome Research. 12: 3697-706. PMID 23763277 DOI: 10.1021/Pr400321X  0.64
2013 Voruganti S, Lacroix JC, Rogers CN, Rogers J, Matts RL, Hartson SD. The anticancer drug AUY922 generates a proteomics fingerprint that is highly conserved among structurally diverse Hsp90 inhibitors Journal of Proteome Research. 12: 3697-3706. DOI: 10.1021/pr400321x  1
2012 Xu W, Mollapour M, Prodromou C, Wang S, Scroggins BT, Palchick Z, Beebe K, Siderius M, Lee MJ, Couvillon A, Trepel JB, Miyata Y, Matts R, Neckers L. Dynamic tyrosine phosphorylation modulates cycling of the HSP90-P50(CDC37)-AHA1 chaperone machine. Molecular Cell. 47: 434-43. PMID 22727666 DOI: 10.1016/J.Molcel.2012.05.015  1
2012 Sun L, Prince T, Manjarrez JR, Scroggins BT, Matts RL. Characterization of the interaction of Aha1 with components of the Hsp90 chaperone machine and client proteins. Biochimica Et Biophysica Acta. 1823: 1092-101. PMID 22504172 DOI: 10.1016/J.Bbamcr.2012.03.014  1
2012 Hartson SD, Matts RL. Approaches for defining the Hsp90-dependent proteome. Biochimica Et Biophysica Acta. 1823: 656-67. PMID 21906632 DOI: 10.1016/J.Bbamcr.2011.08.013  1
2011 Eskew JD, Sadikot T, Morales P, Duren A, Dunwiddie I, Swink M, Zhang X, Hembruff S, Donnelly A, Rajewski RA, Blagg BS, Manjarrez JR, Matts RL, Holzbeierlein JM, Vielhauer GA. Development and characterization of a novel C-terminal inhibitor of Hsp90 in androgen dependent and independent prostate cancer cells. Bmc Cancer. 11: 468. PMID 22039910 DOI: 10.1186/1471-2407-11-468  1
2011 Matts RL, Dixit A, Peterson LB, Sun L, Voruganti S, Kalyanaraman P, Hartson SD, Verkhivker GM, Blagg BS. Elucidation of the Hsp90 C-terminal inhibitor binding site. Acs Chemical Biology. 6: 800-7. PMID 21548602 DOI: 10.1021/Cb200052X  1
2011 Davenport J, Manjarrez JR, Peterson L, Krumm B, Blagg BS, Matts RL. Gambogic acid, a natural product inhibitor of Hsp90. Journal of Natural Products. 74: 1085-92. PMID 21486005 DOI: 10.1021/Np200029Q  1
2011 Zhao H, Brandt GE, Galam L, Matts RL, Blagg BS. Identification and initial SAR of silybin: an Hsp90 inhibitor. Bioorganic & Medicinal Chemistry Letters. 21: 2659-64. PMID 21273068 DOI: 10.1016/J.Bmcl.2010.12.088  1
2011 Matts RL, Brandt GE, Lu Y, Dixit A, Mollapour M, Wang S, Donnelly AC, Neckers L, Verkhivker G, Blagg BS. A systematic protocol for the characterization of Hsp90 modulators. Bioorganic & Medicinal Chemistry. 19: 684-92. PMID 21129982 DOI: 10.1016/J.Bmc.2010.10.029  1
2010 Matthews SB, Vielhauer GA, Manthe CA, Chaguturu VK, Szabla K, Matts RL, Donnelly AC, Blagg BS, Holzbeierlein JM. Characterization of a novel novobiocin analogue as a putative C-terminal inhibitor of heat shock protein 90 in prostate cancer cells. The Prostate. 70: 27-36. PMID 19739131 DOI: 10.1002/Pros.21035  1
2009 Matts RL, Manjarrez JR. Assays for identification of Hsp90 inhibitors and biochemical methods for discriminating their mechanism of action. Current Topics in Medicinal Chemistry. 9: 1462-78. PMID 19860729 DOI: 10.2174/156802609789895692  1
2009 Shelton SN, Shawgo ME, Matthews SB, Lu Y, Donnelly AC, Szabla K, Tanol M, Vielhauer GA, Rajewski RA, Matts RL, Blagg BS, Robertson JD. KU135, a novel novobiocin-derived C-terminal inhibitor of the 90-kDa heat shock protein, exerts potent antiproliferative effects in human leukemic cells. Molecular Pharmacology. 76: 1314-22. PMID 19741006 DOI: 10.1124/Mol.109.058545  1
2009 Hadden MK, Hill SA, Davenport J, Matts RL, Blagg BS. Synthesis and evaluation of Hsp90 inhibitors that contain the 1,4-naphthoquinone scaffold. Bioorganic & Medicinal Chemistry. 17: 634-40. PMID 19101151 DOI: 10.1016/J.Bmc.2008.11.064  1
2007 Hadden MK, Galam L, Gestwicki JE, Matts RL, Blagg BS. Derrubone, an inhibitor of the Hsp90 protein folding machinery. Journal of Natural Products. 70: 2014-8. PMID 18020309 DOI: 10.1021/Np070190S  1
2007 Galam L, Hadden MK, Ma Z, Ye QZ, Yun BG, Blagg BS, Matts RL. High-throughput assay for the identification of Hsp90 inhibitors based on Hsp90-dependent refolding of firefly luciferase. Bioorganic & Medicinal Chemistry. 15: 1939-46. PMID 17223347 DOI: 10.1016/J.Bmc.2007.01.004  1
2006 Colón-Ramos DA, Shenvi CL, Weitzel DH, Gan EC, Matts R, Cate J, Kornbluth S. Direct ribosomal binding by a cellular inhibitor of translation. Nature Structural & Molecular Biology. 13: 103-11. PMID 16429152 DOI: 10.1038/Nsmb1052  1
2006 Harris MB, Bartoli M, Sood SG, Matts RL, Venema RC. Direct interaction of the cell division cycle 37 homolog inhibits endothelial nitric oxide synthase activity. Circulation Research. 98: 335-41. PMID 16410463 DOI: 10.1161/01.Res.0000203564.54250.0B  1
2005 Prince T, Sun L, Matts RL. Cdk2: a genuine protein kinase client of Hsp90 and Cdc37. Biochemistry. 44: 15287-95. PMID 16285732 DOI: 10.1021/Bi051423M  1
2005 Prince T, Matts RL. Exposure of protein kinase motifs that trigger binding of Hsp90 and Cdc37. Biochemical and Biophysical Research Communications. 338: 1447-54. PMID 16269130 DOI: 10.1016/J.Bbrc.2005.10.100  1
2005 Yun BG, Matts JA, Matts RL. Interdomain interactions regulate the activation of the heme-regulated eIF 2 alpha kinase. Biochimica Et Biophysica Acta. 1725: 174-81. PMID 16109458 DOI: 10.1016/J.Bbagen.2005.07.011  1
2005 Yun BG, Matts RL. Hsp90 functions to balance the phosphorylation state of Akt during C2C12 myoblast differentiation. Cellular Signalling. 17: 1477-85. PMID 15935620 DOI: 10.1016/J.Cellsig.2005.03.006  1
2005 Yun BG, Matts RL. Differential effects of Hsp90 inhibition on protein kinases regulating signal transduction pathways required for myoblast differentiation. Experimental Cell Research. 307: 212-23. PMID 15922741 DOI: 10.1016/J.Yexcr.2005.03.003  1
2005 Prince T, Shao J, Matts RL, Hartson SD. Evidence for chaperone heterocomplexes containing both Hsp90 and VCP. Biochemical and Biophysical Research Communications. 331: 1331-7. PMID 15883021 DOI: 10.1016/J.Bbrc.2005.04.047  1
2005 Gheith MK, Sinani VA, Wicksted JP, Matts RL, Kotov NA. Single-walled carbon nanotube polyelectrolyte multilayers and freestanding films as a biocompatible platform for neuroprosthetic implants Advanced Materials. 17: 2663-2670. DOI: 10.1002/Adma.200500366  1
2004 Prince T, Matts RL. Definition of protein kinase sequence motifs that trigger high affinity binding of Hsp90 and Cdc37. The Journal of Biological Chemistry. 279: 39975-81. PMID 15258137 DOI: 10.1074/Jbc.M406882200  1
2004 Yun BG, Huang W, Leach N, Hartson SD, Matts RL. Novobiocin induces a distinct conformation of Hsp90 and alters Hsp90-cochaperone-client interactions. Biochemistry. 43: 8217-29. PMID 15209518 DOI: 10.1021/Bi0497998  1
2004 Inuzuka T, Yun BG, Ishikawa H, Takahashi S, Hori H, Matts RL, Ishimori K, Morishima I. Identification of crucial histidines for heme binding in the N-terminal domain of the heme-regulated eIF2alpha kinase. The Journal of Biological Chemistry. 279: 6778-82. PMID 14672943 DOI: 10.1074/Jbc.C300464200  1
2003 Shao J, Irwin A, Hartson SD, Matts RL. Functional dissection of cdc37: characterization of domain structure and amino acid residues critical for protein kinase binding. Biochemistry. 42: 12577-88. PMID 14580204 DOI: 10.1021/Bi035138J  1
2003 Scroggins BT, Prince T, Shao J, Uma S, Huang W, Guo Y, Yun BG, Hedman K, Matts RL, Hartson SD. High affinity binding of Hsp90 is triggered by multiple discrete segments of its kinase clients. Biochemistry. 42: 12550-61. PMID 14580201 DOI: 10.1021/Bi035001T  1
2003 Shao J, Prince T, Hartson SD, Matts RL. Phosphorylation of serine 13 is required for the proper function of the Hsp90 co-chaperone, Cdc37. The Journal of Biological Chemistry. 278: 38117-20. PMID 12930845 DOI: 10.1074/Jbc.C300330200  1
2003 Sinani VA, Koktysh DS, Yun BG, Matts RL, Pappas TC, Motamedi M, Thomas SN, Kotov NA. Collagen coating promotes biocompatibility of semiconductor nanoparticles in stratified LBL films Nano Letters. 3: 1177-1182. DOI: 10.1021/Nl0255045  1
2002 Ishikawa H, Yun BG, Takahashi S, Hori H, Matts RL, Ishimori K, Morishima I. NO-induced activation mechanism of the heme-regulated eIF2alpha kinase. Journal of the American Chemical Society. 124: 13696-7. PMID 12431098 DOI: 10.1021/Ja0272336  1
2002 Shao J, Hartson SD, Matts RL. Evidence that protein phosphatase 5 functions to negatively modulate the maturation of the Hsp90-dependent heme-regulated eIF2alpha kinase. Biochemistry. 41: 6770-9. PMID 12022881 DOI: 10.1021/Bi025737A  1
2002 Thulasiraman V, Yun BG, Uma S, Gu Y, Scroggins BT, Matts RL. Differential inhibition of Hsc70 activities by two Hsc70-binding peptides. Biochemistry. 41: 3742-53. PMID 11888292 DOI: 10.1021/Bi012137N  1
2002 Koktysh DS, Liang X, Yun BG, Pastoriza-Santos I, Matts RL, Giersig M, Serra-Rodríguez C, Liz-Marzán LM, Kotov NA. Biomaterials by design: Layer-by-layer assembled ion-selective and biocompatible films of TiO2 nanoshells for neurochemical monitoring Advanced Functional Materials. 12: 255-265. DOI: 10.1002/1616-3028(20020418)12:4<255::Aid-Adfm255>3.0.Co;2-1  1
2001 Scholz GM, Hartson SD, Cartledge K, Volk L, Matts RL, Dunn AR. The molecular chaperone Hsp90 is required for signal transduction by wild-type Hck and maintenance of its constitutively active counterpart. Cell Growth & Differentiation : the Molecular Biology Journal of the American Association For Cancer Research. 12: 409-17. PMID 11504706  1
2001 Uma S, Yun BG, Matts RL. The heme-regulated eukaryotic initiation factor 2alpha kinase. A potential regulatory target for control of protein synthesis by diffusible gases. The Journal of Biological Chemistry. 276: 14875-83. PMID 11278914 DOI: 10.1074/Jbc.M011476200  1
2001 Shao J, Grammatikakis N, Scroggins BT, Uma S, Huang W, Chen JJ, Hartson SD, Matts RL. Hsp90 regulates p50(cdc37) function during the biogenesis of the activeconformation of the heme-regulated eIF2 alpha kinase. The Journal of Biological Chemistry. 276: 206-14. PMID 11036079 DOI: 10.1074/Jbc.M007583200  1
2001 Grant GGS, Koktysh DS, Yun B, Matts RL, Kotov NA. Layer-by-layer assembly of collagen thin films: Controlled thickness and biocompatibility Biomedical Microdevices. 3: 301-306. DOI: 10.1023/A:1012456714628  1
2000 Scholz G, Hartson SD, Cartledge K, Hall N, Shao J, Dunn AR, Matts RL. p50(Cdc37) can buffer the temperature-sensitive properties of a mutant of Hck. Molecular and Cellular Biology. 20: 6984-95. PMID 10958693 DOI: 10.1128/Mcb.20.18.6984-6995.2000  1
2000 Hartson SD, Irwin AD, Shao J, Scroggins BT, Volk L, Huang W, Matts RL. p50(cdc37) is a nonexclusive Hsp90 cohort which participates intimately in Hsp90-mediated folding of immature kinase molecules. Biochemistry. 39: 7631-44. PMID 10858314 DOI: 10.1021/Bi000315R  1
2000 Marissen WE, Guo Y, Thomas AAM, Matts RL, Lloyd RE. Identification of caspase 3-mediated cleavage and functional alteration of eukaryotic initiation factor 2α in apoptosis Journal of Biological Chemistry. 275: 9314-9323. PMID 10734073 DOI: 10.1074/jbc.275.13.9314  1
2000 Yorgin PD, Hartson SD, Fellah AM, Scroggins BT, Huang W, Katsanis E, Couchman JM, Matts RL, Whitesell L. Effects of geldanamycin, a heat-shock protein 90-binding agent, on T cell function and T cell nonreceptor protein tyrosine kinases. Journal of Immunology (Baltimore, Md. : 1950). 164: 2915-23. PMID 10706677 DOI: 10.4049/Jimmunol.164.6.2915  1
2000 Rafie-Kolpin M, Chefalo PJ, Hussain Z, Hahn J, Uma S, Matts RL, Chen JJ. Two heme-binding domains of heme-regulated eukaryotic initiation factor- 2α kinase. N terminus and kinase insertion Journal of Biological Chemistry. 275: 5171-5178. PMID 10671563 DOI: 10.1074/Jbc.275.7.5171  1
2000 Uma S, Matts RL, Guo Y, White S, Chen JJ. The N-terminal region of the heme-regulated elF2α kinase is an autonomous heme binding domain European Journal of Biochemistry. 267: 498-506. PMID 10632719 DOI: 10.1046/J.1432-1327.2000.01021.X  1
1999 Uma S, Thulasiraman V, Matts RL. Dual role for Hsc70 in the biogenesis and regulation of the heme-regulated kinase of the alpha subunit of eukaryotic translation initiation factor 2. Molecular and Cellular Biology. 19: 5861-71. PMID 10454533 DOI: 10.1128/Mcb.19.9.5861  1
1999 Lele Z, Hartson SD, Martin CC, Whitesell L, Matts RL, Krone PH. Disruption of zebrafish somite development by pharmacologic inhibition of Hsp90 Developmental Biology. 210: 56-70. PMID 10364427 DOI: 10.1006/Dbio.1999.9262  1
1999 Hartson SD, Thulasiraman V, Huang W, Whitesell L, Matts RL. Molybdate inhibits hsp90, induces structural changes in its C-terminal domain, and alters its interactions with substrates. Biochemistry. 38: 3837-49. PMID 10090774 DOI: 10.1021/Bi983027S  1
1998 Thulasiraman V, Xu Z, Uma S, Gu Y, Chen JJ, Matts RL. Evidence that Hsc70 negatively modulates the activation of the heme-regulated eIF-2alpha kinase in rabbit reticulocyte lysate. European Journal of Biochemistry / Febs. 255: 552-62. PMID 9738893 DOI: 10.1046/J.1432-1327.1998.2550552.X  1
1998 Thulasiraman V, Matts RL. Luciferase renaturation assays of chaperones and chaperone antagonists. Methods in Molecular Biology (Clifton, N.J.). 102: 129-41. PMID 9680615 DOI: 10.1385/0-89603-520-4:129  1
1998 Hartson SD, Ottinger EA, Huang W, Barany G, Burn P, Matts RL. Modular folding and evidence for phosphorylation-induced stabilization of an hsp90-dependent kinase. The Journal of Biological Chemistry. 273: 8475-82. PMID 9525961 DOI: 10.1074/Jbc.273.14.8475  1
1998 Uma S, Barret DJ, Matts RL. Changes in the expression of the heme-regulated eIF-2α kinase and heat shock proteins in rabbit reticulocytes maturing during recovery from anemia Experimental Cell Research. 238: 273-282. PMID 9457081 DOI: 10.1006/Excr.1997.3860  1
1997 Heminger KA, Hartson SD, Rogers J, Matts RL. Cisplatin inhibits protein synthesis in rabbit reticulocyte lysate by causing an arrest in elongation Archives of Biochemistry and Biophysics. 344: 200-207. PMID 9244398 DOI: 10.1006/Abbi.1997.0198  1
1997 Xu Z, Pal JK, Thulasiraman V, Hahn HP, Chen JJ, Matts RL. The role of the 90-kDa heat-shock protein and its associated cohorts in stabilizing the heme-regulated eIF-2alpha kinase in reticulocyte lysates during heat stress. European Journal of Biochemistry / Febs. 246: 461-70. PMID 9208939 DOI: 10.1111/J.1432-1033.1997.T01-1-00461.X  1
1997 Uma S, Hartson SD, Chen JJ, Matts RL. Hsp90 is obligatory for the heme-regulated eIF-2α kinase to acquire and maintain an activable conformation Journal of Biological Chemistry. 272: 11648-11656. PMID 9111082 DOI: 10.1074/Jbc.272.17.11648  1
1996 Hartson SD, Barrett DJ, Burn P, Matts RL. Hsp90-mediated folding of the lymphoid cell kinase p56(lck) Biochemistry. 35: 13451-13459. PMID 8873614 DOI: 10.1021/Bi961332C  1
1996 Thulasiraman V, Matts RL. Effect of geldanamycin on the kinetics of chaperone-mediated renaturation of firefly luciferase in rabbit reticulocyte lysate. Biochemistry. 35: 13443-50. PMID 8873613 DOI: 10.1021/Bi9615396  1
1996 Benton PA, Barrett DJ, Matts RL, Lloyd RE. The outcome of poliovirus infections in K562 cells is cytolytic rather than persistent after hemin-induced differentiation Journal of Virology. 70: 5525-5532. PMID 8764065 DOI: 10.1128/Jvi.70.8.5525-5532.1996  1
1996 Flowers KM, Mellor H, Matts RL, Kimball SR, Jefferson LS. Cloning and characterization of complementary and genomic DNAs encoding the epsilon-subunit of rat translation initiation factor-2B. Biochimica Et Biophysica Acta. 1307: 318-24. PMID 8688467 DOI: 10.1016/0167-4781(96)00055-3  1
1996 Asuru AI, Mellor H, Thomas NSB, Yu L, Chen JJ, Crosby JS, Hartson SD, Kimball SR, Jefferson LS, Matts RL. Cloning and characterization of cDNAs encoding the ε-subunit of eukaryotic initiation factor-2B from rabbit and human Biochimica Et Biophysica Acta - Gene Structure and Expression. 1307: 309-317. PMID 8688466 DOI: 10.1016/0167-4781(96)00054-1  1
1996 Petryshyn R, Chen JJ, Danley L, Matts RL. Effect of interferon on protein translation during growth stages of 3T3 cells Archives of Biochemistry and Biophysics. 326: 290-297. PMID 8611036 DOI: 10.1006/Abbi.1996.0078  1
1994 Schumacher RJ, Hurst R, Sullivan WP, McMahon NJ, Toft DO, Matts RL. ATP-dependent chaperoning activity of reticulocyte lysate Journal of Biological Chemistry. 269: 9493-9499. PMID 8144534  1
1994 Hartson SD, Matts RL. Association of Hsp90 with cellular Src-family kinases in a cell-free system correlates with altered kinase structure and function Biochemistry. 33: 8912-8920. PMID 8043579 DOI: 10.1021/Bi00196A008  1
1993 Bushman JL, Asuru AI, Matts RL, Hinnebusch AG. Evidence that GCD6 and GCD7, translational regulators of GCN4, are subunits of the guanine nucleotide exchange factor for eIF-2 in Saccharomyces cerevisiae Molecular and Cellular Biology. 13: 1920-1932. PMID 8441423 DOI: 10.1128/Mcb.13.3.1920  1
1993 Matts RL. Denatured proteins inhibit translation in hemin-supplemented rabbit reticulocyte lysate by inducing the activation of the heme-regulated eIF-2α kinase Biochemistry. 32: 7323-7328. PMID 8101730 DOI: 10.1021/Bi00080A001  1
1992 Matts RL, Hurst R. The relationship between protein synthesis and heat shock proteins levels in rabbit reticulocyte lysates Journal of Biological Chemistry. 267: 18168-18174. PMID 1517246  1
1992 Matts RL, Xu Z, Pal JK, Chen JJ. Interactions of the heme-regulated eIF-2α kinase with heat shock proteins in rabbit reticulocyte lysates Journal of Biological Chemistry. 267: 18160-18167. PMID 1355482  1
1991 Matts RL, Schatz JR, Hurst R, Kagen R. Toxic heavy metal ions activate the heme-regulated eukaryotic initiation factor-2α kinase by inhibiting the capacity of hemin-supplemented reticulocyte lysates to reduce disulfide bonds Journal of Biological Chemistry. 266: 12695-12702. PMID 1676400  1
1989 Matts RL, Hurst R. Evidence for the association of the heme-regulated eIF-2α kinase with the 90-kDa heat shock protein in rabbit reticulocyte lysate in situ Journal of Biological Chemistry. 264: 15542-15547. PMID 2768277  1
1988 Matts RL, Thomas NS, Hurst R, London IM. Correlation between the distribution of the reversing factor and eukaryotic initiation factor 2 in heme-deficient or double-stranded RNA-inhibited reticulocyte lysates. Febs Letters. 236: 179-84. PMID 3402612 DOI: 10.1016/0014-5793(88)80310-7  1
1987 Hurst R, Schatz JR, Matts RL. Inhibition of rabbit reticulocyte lysate protein synthesis by heavy metal ions involves the phosphorylation of the α-subunit of the eukaryotic initiation factor 2 Journal of Biological Chemistry. 262: 15939-15945. PMID 3680235  1
1987 Hurst R, Matts RL. Phosphorothioated binary complex of eukaryotic initiation factor eIF-2 and GDP inhibits protein synthesis in hemin-supplemented reticulocyte lysates Biochemical and Biophysical Research Communications. 147: 772-777. PMID 3632699 DOI: 10.1016/0006-291X(87)90997-1  1
1987 London IM, Levin DH, Matts RL, Thomas NSB, Petryshyn R, Chen JJ. 12 Regulation of Protein Synthesis Enzymes. 18: 359-380. DOI: 10.1016/S1874-6047(08)60263-2  1
1986 Thomas NS, Matts RL, London IM. The storage of globin mRNA during the inhibition of protein synthesis by heme deprivation. Biochemical and Biophysical Research Communications. 134: 1048-55. PMID 3947357 DOI: 10.1016/0006-291X(86)90357-8  1
1986 Matts RL, Levin DH, London IM. Fate of reversing factor during restoration of protein synthesis by hemin or GTP in heme-deficient reticulocyte lysates. Proceedings of the National Academy of Sciences of the United States of America. 83: 1217-21. PMID 3456582 DOI: 10.1073/Pnas.83.5.1217  1
1985 Thomas NS, Matts RL, Levin DH, London IM. The 60 S ribosomal subunit as a carrier of eukaryotic initiation factor 2 and the site of reversing factor activity during protein synthesis. The Journal of Biological Chemistry. 260: 9860-6. PMID 3926772  1
1984 Matts RL, London IM. The regulation of initiation of protein synthesis by phosphorylation of eIF-2(alpha) and the role of reversing factor in the recycling of eIF-2. The Journal of Biological Chemistry. 259: 6708-11. PMID 6725267  1
1984 Thomas NS, Matts RL, Petryshyn R, London IM. Distribution of reversing factor in reticulocyte lysates during active protein synthesis and on inhibition by heme deprivation or double-stranded RNA. Proceedings of the National Academy of Sciences of the United States of America. 81: 6998-7002. PMID 6594676 DOI: 10.1073/Pnas.81.22.6998  1
1984 Matts RL, London IM. Measurement of reversing factor activity in the reticulocyte lysate in situ: Correlation with the rate of protein synthesis Federation Proceedings. 43: no. 368.  1
1984 Thomas SNB, Matts RL, London IM. Localization of RF activity and eIF-2α phopshorylation in the reticulocyte lysate in situ Federation Proceedings. 43: no. 3255.  1
1983 Matts RL, Levin DH, London IM. Effect of phosphorylation of the alpha-subunit of eukaryotic initiation factor 2 on the function of reversing factor in the initiation of protein synthesis. Proceedings of the National Academy of Sciences of the United States of America. 80: 2559-63. PMID 6573671 DOI: 10.1073/Pnas.80.9.2559  1
1979 Matts RL, Siegel FL. Regulation of hepatic poly(A) endonuclease by corticosterone and amino acids. The Journal of Biological Chemistry. 254: 11228-33. PMID 500640  1
Show low-probability matches.